Pharmafile Logo
Pharmafocus logo
Advanced Search
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 29, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ablynx, Cancer, GSK, Hemlibra, MSD, Roche, Sun Pharma, Takeda, brexit, pharma, tecentriq, top ten

As we approach the Easter weekend, we at Pharmafocus hope all of our readers have a great long weekend, if …

News
handshake2

bluebird backs own CAR-T prospect, takes option to co-develop with Celgene

March 29, 2018
Sales and Marketing Bluebird Bio, CAR T, CAR-T, Celgene, biotech, drugs, pharma, pharmaceutical

Biotech companies showing faith in their own prospect drug candidates is not an unusual occurrence, some do it to extremes. …

News
shutterstock_92671375

Teva spared payout to GSK over patent infringement dispute

March 29, 2018
Sales and Marketing Coreg, GSK, GlaxoSmithKline, Teva, carvedilol, heart failure, pharma

Teva has been spared a sizeable payout to GlaxoSmithKline after a federal judge overturned a US jury verdict demanding that …

News
tokyo-midtown-west-building-overview_fujifilm

Fujifilm bolsters healthcare with two biotech buys for $800m

March 29, 2018
Sales and Marketing Fujifilm, biotech, drugs, pharma, pharmaceutical

Fujifilm has made no secret of the fact it is looking to switch up part of its core business to …

News
shire_image

Takeda moots Shire move but big questions remain

March 28, 2018
Sales and Marketing Shire, Takeda, biotech, drugs, pharma, pharmaceutical

Takeda is considering making a bold move for Shire, after announcing, as per UK regulations, that it may make an …

News
shutterstock_168864905

InSight Innovations to buy CureTech in $550m deal

March 28, 2018
Research and Development, Sales and Marketing Cancer, CureTech, Insight Innovations, Pfizer, Teva, brain cancer, brain tumour, immunotherapy, israel

Israeli drug firm CureTech is be sold for the third time in four years, this time to InSight Innovations in …

News
genentechlr_copy

Five deaths linked to Roche’s haemophilia drug Hemlibra

March 28, 2018
Research and Development Genentech, Hemlibra, Roche, haemophilia, pharma

Roche has been rocked by the revelation that there have been five patient deaths linked to the use of its …

News

Pfizer seeks tax breaks in return for planned $456m facility

March 28, 2018
Manufacturing and Production, Research and Development Michigan, Pfizer, biotech, drugs, pharma, pharmaceutical, tax break

Pfizer has submitted proposals to officials in Portage, Michigan, for a major expansion of its manufacturing site in the city. …

News
theresa_may_-_credit_arno_mikkor

May hints at providing long-term funding plan for NHS

March 28, 2018
Medical Communications, Research and Development Conservatives, NHS, Theresa May, UK government, biotech, drugs, pharma, pharmaceutical

After the news broke earlier in the week of a group of nearly 100 MPs calling for a parliamentary commission …

News
brexit-referendum-uk-1468255193y2p

Brexit Health Alliance: Brexit and the impact on patient access to medicines

March 28, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brexit Health Alliance, brexit, feature, market access, pharma

On behalf of the Brexit Health Alliance, Sarah Collen, Senior Policy Manager at NHS Confederation, details the potential negative fallout …

Feature
skin-222664_960_720

New organ discovery has implications for cancer treatment

March 27, 2018
Research and Development biotech, drugs, pharma, pharmaceutical

The discovery of an entirely new organ, the 80th to be discovered in the human body, could have serious implications …

News
abbvie_0

Abbvie pays out over $3m after its testosterone replacement drug leads to heart attack

March 27, 2018
Manufacturing and Production, Sales and Marketing AbbVie, Endo, GSK, androgel, heart attack, pharma

Abbvie has been ordered to pay over $3 million in damages to a man who asserts that the uise of …

News
headache

Reaction mixed to Biohaven’s migraine drug results

March 27, 2018
Manufacturing and Production, Research and Development Allergan, Biohaven, CGRP, biotech, drugs, migraine, pharma, pharmaceutical

Biohaven is full of confidence in its lead drug, rimegepant, evidenced only a few weeks ago when it decided to …

News

GSK to take control of Consumer Healthcare in £9.2bn buyout

March 27, 2018
Manufacturing and Production, Sales and Marketing Consumer Health Care, GSK, Novartis, biotech, drugs, horlicks, pharma, pharmaceutical

GSK has announced that it plans to purchase Novartis’ 36.5% stake in the joint Consumer Healthcare Business for a sum …

News
pharmafocus_april_2018_cover

The April 2018 issue of Pharmafocus is now live!

March 27, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Janssen, Martin Shkreli, Right to try, atrial fibrillation, falsified medicines directive, oncology, opioids, pharma

As we finally pass into Spring after what still feels like a particularly stubborn Winter, we are pleased to announce …

News

Seattle Genetics gain breakthrough therapy designation

March 26, 2018
Manufacturing and Production, Sales and Marketing Astellas, Seattle Genetics, biotech, drugs, pharma, pharmaceutical

Seattle Genetics and Astellas have confirmed that the drug candidate they are co-developing, enfortumab, has been given FDA breakthrough therapy …

News
ablynx_flags-web

Ablynx’s vobarilizumab trial fails and sees two patient deaths in systemic lupus erythematosus

March 26, 2018
Research and Development, Sales and Marketing AbbVie, Ablynx, Sanofi, Vobarilizumab, pharma, systemic lupus erythematosus

Ablynx has revealed that its interleukin 6 pathway via its IL-6 receptor (IL-6R) vobarilizumab failed to meet its primary endpoint …

News
eu-flag-2108026_960_720

Six reasons why UK pharma has more to gain, than fear, from Brexit

March 26, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, biotech, brexit, drugs, hard Brexit, pharma, pharmaceutical

There are good reasons to think exiting the EU represents a major opportunity for this dynamic and world-leading industry, argues …

Feature
european_commission_web

Takeda and TiGenix’s Alofisel becomes first donor-derived stem cell therapy approved in Europe

March 26, 2018
Sales and Marketing Crohn’s disease, EU, Europe, European Commission, Takeda, TiGenix, crohn's disease, pharma

The European Commission has awarded approval to Takeda and TiGenix’s allogeneic expanded adipose-derived stem cell (eASC) therapy Alofisel (darvadstrocel) for …

News

May faces pressure for cross-party talks over NHS future

March 26, 2018
Medical Communications, Sales and Marketing NHS, Theresa May, UK government, biotech, drugs, pharma, pharmaceutical

A group of close to 100 MPs have demanded that Theresa May set up a parliamentary commission to plot the …

News
The Gateway to Local Adoption Series

Latest content

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026